In a study, 8.8% of clinically relevant prostate cancers detected by systematic biopsy were missed by MRI-targeted biopsy. In men with prostate lesions visible on multiparametric magnetic resonance ...
MRI/ultrasonography (MRI/US)-fusion biopsy outperforms systematic ultrasonography-guided biopsy, detecting more high-grade prostate tumours while being less able to detect low-grade cancer, thus ...
Gemcitabine/cisplatin in patients with advanced bladder and impaired renal function: A retrospective analysis. Background: Multiple MRI techniques (T2W, dynamic contrast enhancement (DCE), ...
Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...
Results from the phase 3 PRECISE trial showed that MRI with targeted biopsies matched or exceeded the accuracy of the current standard for detecting clinically significant prostate cancer. The current ...
Active surveillance (AS) is commonly based on standard 10–12-core prostate biopsies, which misclassify ~50% of cases compared with radical prostatectomy. We assessed the value of multiparametric ...
Toronto - (February 4, 2021) The results of a Phase III randomized clinical trial have shown that when it comes to detecting clinically significant prostate cancer, Magnetic Resonance Imaging (MRI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback